ClinicalTrials.Veeva

Menu

Developing a Childhood Asthma Risk Passive Digital Marker

Indiana University logo

Indiana University

Status

Terminated

Conditions

Pediatric Asthma

Treatments

Other: Childhood Asthma Passive Digital Marker

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05826561
15873
K01HL166436 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Underdiagnosis and undertreatment is a major problem in childhood asthma management, especially in preschool-aged children. Current prognostic approaches using risk-score based tools have poor-to-modest accuracy, are impractical, and have limited evidence of efficacy in clinical settings and hence are not widely used in practice.

The objective of the study is to determine the usability, acceptability, feasibility, and preliminary efficacy of the childhood asthma passive digital marker (PDM) among pediatricians. The study will include practicing pediatricians within the IU Health Network.

Enrollment

34 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

• Practicing pediatricians within the IU Health Network

Exclusion criteria

• Non-practicing pediatricians within the IU Health Network

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

34 participants in 4 patient groups

Control Clinicians - post test only
No Intervention group
Description:
N=25 control pediatric clinicians, who will receive the post test only. Each clinician will be presented with 10 randomly selected vignettes of 10 children \[5 with and 5 without asthma\] and asked to provide a prediction of a child's asthma risk at 6-10 years.
PDM Intervention Clinicians - post test only
Experimental group
Description:
N=25 intervention pediatric clinicians, who will receive the post test only. Using the PDM, each clinician will be presented with 10 randomly selected vignettes of 10 children \[5 with and 5 without asthma\] and asked to provide a prediction of a child's asthma risk at 6-10 years.
Treatment:
Other: Childhood Asthma Passive Digital Marker
Control Clinicians - pre and post test
No Intervention group
Description:
N=25 control pediatric clinicians, who will receive the pre and post test. Each clinician will be presented with 10 randomly selected vignettes of 10 children \[5 with and 5 without asthma\] and asked to provide a prediction of a child's asthma risk at 6-10 years.
PDM Intervention Clinicians - pre and post test
Active Comparator group
Description:
N=25 intervention pediatric clinicians, who will receive the pre and post test. Using the PDM, each clinician will be presented with 10 randomly selected vignettes of 10 children \[5 with and 5 without asthma\] and asked to provide a prediction of a child's asthma risk at 6-10 years.
Treatment:
Other: Childhood Asthma Passive Digital Marker

Trial contacts and locations

1

Loading...

Central trial contact

Arthur H Owora, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems